Compare NBTB & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTB | AORT |
|---|---|---|
| Founded | 1856 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 1995 | 1996 |
| Metric | NBTB | AORT |
|---|---|---|
| Price | $42.72 | $38.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $52.00 | $48.76 |
| AVG Volume (30 Days) | 194.4K | ★ 476.1K |
| Earning Date | 04-27-2026 | 05-15-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | 12.12 | ★ 165.62 |
| EPS | ★ 3.33 | 0.21 |
| Revenue | $182,952,000.00 | ★ $298,836,000.00 |
| Revenue This Year | $14.37 | $13.95 |
| Revenue Next Year | $5.15 | $11.16 |
| P/E Ratio | ★ $18.87 | $182.86 |
| Revenue Growth | 10.40 | ★ 18.01 |
| 52 Week Low | $37.31 | $21.97 |
| 52 Week High | $46.92 | $48.25 |
| Indicator | NBTB | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 39.90 | 45.61 |
| Support Level | $41.90 | $30.24 |
| Resistance Level | $42.97 | $44.29 |
| Average True Range (ATR) | 1.36 | 1.73 |
| MACD | -0.39 | 0.19 |
| Stochastic Oscillator | 27.69 | 64.76 |
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.